VFA
LFCR icon

Virtus Fund Advisers’s Lifecore Biomedical LFCR Stock Holding History

Virtus Fund Advisers’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,285
Closed -$29K – 1562
2014
Q2 		$29K Buy
+2,285
New +$26.9K ﹤0.01% 2223

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Virtus Fund Advisers's LFCR Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Lifecore Biomedical (LFCR) in Q3 2014, closing a stake of 2,285 shares — an estimated $29K sold.

Virtus Fund Advisers first reported a position in LFCR in Q2 2014 and held it in 1 quarter. The position peaked at $29K in Q2 2014. 107 funds tracked by Wall St. Rank hold LFCR as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Lifecore Biomedical position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 2,285 Lifecore Biomedical shares in Q3 2014, an estimated $29K.
  • Virtus Fund Advisers first reported a position in Lifecore Biomedical in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Lifecore Biomedical position peaked at $29K in Q2 2014.
  • 107 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.